trigger finger trigger finger,
Conditions
Interventions
triamcinolone acetonide does 5 mg (0.5 ml) plus 1%lidocaine (0.5 ml) ,triamcinolone acetonide does 10 mg (1ml) ,triamcinolone acetonide does 20 mg (0.5 ml) plus 1%lidocaine (0.5 ml)
Active Comparator Drug,Active Comparator Drug,Active Comparator Drug
triamcinolone acetonide does 5 mg,triamcinolone acetonide does 10 mg,triamcinolone acetonide does 20 mg
Sponsors
Mahavajiralongkorn Foundation
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: trigger finger grade II - III
Exclusion criteria
Exclusion criteria: 1. Patient who has the underlying such as DM, RA, OA of the fingers, gout and chronic renal disease. 2. Patient who has the history of trauma associated with the investigated finger. 3. Patient who has tenosynovitis of the investigated finger.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrent rate 2 weeks, 1.5 month, 3 months, 6 months physical examination | — |
Secondary
| Measure | Time frame |
|---|---|
| complications 2 weeks, 1.5 month, 3 months, 6 months physical examination | — |
Contacts
Public ContactArkaphat Kosiyatrakul
Department of Orthopedics, Phramongkutklao Hospital and College of Medicine
Outcome results
None listed